PHASE-I STUDY AND PHARMACOKINETICS OF CPT-11 WITH 5-DAY CONTINUOUS INFUSION

被引：135

作者：

OHE, Y ^{[1
]}

SASAKI, Y ^{[1
]}

SHINKAI, T ^{[1
]}

EGUCHI, K ^{[1
]}

TAMURA, T ^{[1
]}

KOJIMA, A ^{[1
]}

KUNIKANE, H ^{[1
]}

OKAMOTO, H ^{[1
]}

KARATO, A ^{[1
]}

OHMATSU, H ^{[1
]}

KANZAWA, F ^{[1
]}

SAIJO, N ^{[1
]}

机构：

[1] NATL CANC CTR,RES INST,DIV PHARMACOL,TOKYO 104,JAPAN

来源：

关键词：

D O I：

10.1093/jnci/84.12.972

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：972 / 974

页数：3

共 22 条

[1] CHARACTERIZATION OF A MAMMALIAN MUTANT WITH A CAMPTOTHECIN-RESISTANT DNA TOPOISOMERASE-I
ANDOH, T
ISHII, K
SUZUKI, Y
IKEGAMI, Y
KUSUNOKI, Y
TAKEMOTO, Y
OKADA, K
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) : 5565 - 5569
[2] A PHASE-II STUDY OF CPT-11, A NEW DERIVATIVE OF CAMPTOTHECIN, FOR PREVIOUSLY UNTREATED NON-SMALL-CELL LUNG-CANCER
FUKUOKA, M
NIITANI, H
SUZUKI, A
MOTOMIYA, M
HASEGAWA, K
NISHIWAKI, Y
KURIYAMA, T
ARIYOSHI, Y
NEGORO, S
MASUDA, N
NAKAJIMA, S
TAGUCHI, T
ASAKAWA, M
NAKABAYASI, T
NAKAI, T
KURITA, Y
KINAMERI, K
NOMURA, K
NAGAO, K
SAIJO, N
OHE, Y
SUGIURA, T
SHIMOKATA, K
SAKA, H
NEGORO, S
NAKAJIMA, S
TOHDA, Y
FUJII, M
OTA, M
HARA, N
HARA, Y
FUJISAWA, K
NAKANO, S
ARAKI, J
NIITANI, H
MIYATA, Y
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) : 16 - 20
[3] FURUTA T, 1988, JPN J CANC CHEMOTHER, V15, P2757
[4] KANEDA N, 1990, CANCER RES, V50, P1721
[5] KANEDA N, 1990, CANCER RES, V50, P1715
[6] KANZAWA F, 1990, CANCER RES, V50, P5919
[7] ANTITUMOR-ACTIVITY OF A CAMPTOTHECIN DERIVATIVE, CPT-11, AGAINST HUMAN TUMOR XENOGRAFTS IN NUDE-MICE
KAWATO, Y
FURUTA, T
AONUMA, M
YASUOKA, M
YOKOKURA, T
MATSUMOTO, K
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (03) : 192 - 198
[8] KUNIMOTO T, 1987, CANCER RES, V47, P5944
[9] MATSUZAKI T, 1988, CANCER CHEMOTH PHARM, V21, P308
[10] MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO